Cue Health to Announce Second Quarter 2022 Financial Results

Rhea-AI Summary

Cue Health Inc. (NASDAQ: HLTH) is set to release its Q2 2022 financial results on August 10, 2022, at 1:30 p.m. PT. A conference call will be held to discuss these results and recent developments. Interested participants can register in advance to access the call and receive a unique PIN. Cue Health, established in 2010 and headquartered in San Diego, specializes in healthcare technology with a focus on providing accessible, lab-quality diagnostics. The company is known for its FDA-authorized at-home COVID-19 test.

Positive

• Cue Health is recognized for its innovative healthcare technology solutions.
• The company's diagnostic tests, including COVID-19 tests, have received multiple international regulatory approvals.

Negative

• None.

SAN DIEGO--(BUSINESS WIRE)-- Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its second quarter 2022 financial results on Wednesday, August 10, 2022. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

To access the live call via telephone, please register in advance using the link here. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique personal PIN that can be used to join the call.

The live webinar of the call may be accessed by visiting the Events section of the Company’s website at investors.cuehealth.com. A replay of the webinar will be available on the Company’s website shortly after the conclusion of the call.

About Cue Health
Cue is a healthcare technology company that makes it easy for individuals to access health information and places diagnostic information at the center of care. Cue enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue’s first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Outside the United States, Cue has received the CE mark in the European Union, Interim Order authorization from Health Canada, regulatory approval from India's Central Drugs Standard Control Organization, and PSAR authorization from Singapore's Health Sciences Authority. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220727005142/en/

Lorna Williams

ir@cuehealth.com

Cue Health

press@cuehealth.com

Source: Cue Health Inc.

FAQ

When will Cue Health release its Q2 2022 financial results?

Cue Health will release its Q2 2022 financial results on August 10, 2022.

What time is the Cue Health conference call for Q2 2022 results?

The conference call will take place at 1:30 p.m. Pacific Time on August 10, 2022.

How can I access the Cue Health Q2 2022 financial results conference call?

Participants must register in advance to access the Cue Health Q2 2022 conference call.

What is Cue Health known for?

Cue Health is known for its healthcare technology solutions and for being the first company to obtain FDA authorization for at-home COVID-19 testing.